March 12, 2012

Direct Relief USA Offer of Lo Seasonique

We would like to inform you of the program Direct Relief - offering members Lo Seasonique birth control pills at no cost.

Direct Relief USA offer of Lo Seasonique:

Direct Relief USA, through a donation from TEVA Pharmaceuticals, is working with to provide safety net providers with women’s health products for their uninsured, low-income patients.  Through this program, community clinics, free clinics, and health centers can obtain LoSeasonique birth control pills for their patients without health insurance at no cost.

Direct Relief works with safety net clinics throughout the U.S. that provide care to uninsured patients regardless of their ability to pay.  In 2011, shipments containing medications, medical products and supplies - valued at over $53 million (wholesale) - were sent to 1,102 partners across the U.S. Shipments are sent courtesy of FedEx so partners do not incur any expenses associated with participating in Direct Relief’s programs.  Direct Relief is VAWD accredited and is the only non-profit licensed to distribute medications in all 50 states.  

 

HOW TO PARTICIPATE

Are you already a member of the Direct Relief Network?

To request LoSeasonique, please visit the Direct Relief Network. You will need your Direct Relief Network User ID and Password. If you need help logging in, please contact usaprograms@directrelief.org or call 1-877-30-DR-USA.

Do you want to become a member of the Direct Relief Network?

Your clinic or health center may already be a member, please check with your staff to see if your facility already has an account with Direct Relief.

By partnering with Direct Relief USA, your clinic/health center will be eligible to request LoSeasonique and will receive notifications of product offers available through Direct Relief’s Safety Net Support program. To become a partner, please visit the Direct Relief Networkand click on “Healthcare Providers.”

If you have any questions, contact us at usaprograms@directrelief.org or call 1-877-30-DR-USA.

March 12, 2012 in Coupons , Oral Contraceptives , Women’s Health | Permalink | TrackBack (0)

March 01, 2012

An Important Drug Recall from Glenmark Generics

We would like to inform you of the important Drug Recall on Norgestimate and Ethinyl Estradiol Tablets USP sent from Glenmark-Generics. 

Glenmark-Generics is recalling seven (7) lots of Norgestimate and Ethinyl Estradiol Tablets USP, 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, 0.25 mg/0.035 mg.  Glenmark Generics issued a voluntary, nationwide, consumer-level recall because of packaging error, where select blisters were rotated 180 degrees within the card, reversing the weekly tablet orientation and making the lot number and expiry date visible only in the outer pouch.  Any blister for which the lot number and expiry date is not visible is subject to recall.

These tablets were manufactured and packaged by Glenmark Generics Ltd. India. and are distributed by Glenmark Generics Inc.USA.  This product was distributed to wholesalers and retail pharmacies nationwide between September 21, 2011 and December 30, 2011.

Lot numbers of affected packs of Norgestimate and Ethinyl Estradiol Tablets USP, 0.18 mg/0.035 mg, 0.215 mg, 0.035 mg, 0.25 mg/0.035 mg, (Generic) are as follows:

 

NDC                                            Lot Nos                            Expiration

68462-565-29                              04110101                          7/31/2013

                                                  04110106                          7/31/2013

                                                  04110107                          7/31/2013

                                                  04110114                          8/31/2013

                                                  04110124                          8/31/2013

                                                  04110129                          8/31/2013

                                                  04110134                          9/30/2013

Any adverse events that may be related to the use of these products should be reported to Glenmark Generics, Inc., USA at 1-(888) 721-7115 (8 AM to 5 PM Mon-Fri EST) or to FDA’s Med Watch Program either online, by regular mail or by fax.

 

   Online:                  www.fda.gov/medwatch/report.htm

Regular Mail:            Use postage-paid, pre-addresses Form FDA 3500 available at: www.fda.gov/MedWatch/getforms.htm. Mail to the address on the pre-addressed form.

    Fax:                     1-800-FDA-0178

 

March 1, 2012 in Glenmark-Generics , News , Oral Contraceptives , Pharmaceutical Products , Pharmaceuticals , Vendors | Permalink | TrackBack (0)

January 17, 2012

An Important Drug Recall - LO/OVRAL-28 and Norgestrel 0.3mg/Ethinyl Estradiol 0.03mg Tablets

Following is a Pfizer generated document we received on Friday, January 13, 2012:

 

Pfizer Inc. is recalling multiple lots of LO/OVRAL - 28 Tablets and Norgestrel 0.3mg/Ethinyl Estradiol 0.03mgTablets manufactured and packaged by Pfizer, and distributed and commercialized by Akrimax Pharmaceuticals, LLC (see below for lot numbers and expiration dates).  Please note that these products are labeled with Akrimax labeling.  Pfizer Inc. voluntarily initiated this recall when it was determined that some blister packs may contain an inexact count of placebo or active ingredient tablets.  Please note that use of this product is not likely to cause adverse health consequences.

 

FEDERAL REGULATIONS REQUIRE THAT YOU RESPOND TO THIS RECALL, EVEN IF YOU DO NOT HAVE THE RECALLED PRODUCT. TO RESPOND, PLEASE CONTACT STERICYCLE INC. AT 1(800)-805-3093 WITHIN FIVE (5) BUSINESS DAYS.

 

The recall of LO/OVRAL - 28 Tablets and Norgestrel 0.3mg/Ethinyl Estradiol 0.03 mg Tablets is being conducted to the retail level.

 

Records indicate that you may have received shipment of affected lots between January 2011 and December 2011.  Please check your stock immediately against the table below.  If you have any of the affected products in your inventory, please stop distribution and promptly return to Stericycle Inc. 2670 Executive Drive, Suite A Indianapolis, IN 46241: Attn: Event 2568.  Please contact Stericycle Inc. at (800) 805-3093 if you require the pre-paid UPS labels.  If you have any medical inquiries regarding these products, please contact Akrimax Medical Information at 1(877)509-3935 (8 AM to 7 PM Mon-Fri CST).

 

If you have further distributed the lots to the retail level, please conduct a sub-recall and communicate this recall information to those accounts immediately.  Please request that they immediately cease distribution of the affected lots and promptly return the product directly to the above address.  If they have inventory of the affected product, they can contact Stericycle Inc. at (800) 805-3093 to obtain pre-paid shipping labels for product return.  Further authorization is not required for product return.  Reimbursement for the returned product will be made by credit memorandum.  If you have any questions regarding the reimbursement, please contact your Akrimax Customer Service Representative at 1(877) 509-3935 (8 AM to 7 PM Mon-Fri CST).

 

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.  We appreciate your immediate attention and cooperation to this matter.

 

LO/OVRAL® - 28 

LOT#         Expiration Date

E15678        8/31/2013

E15679        8/31/2013

E15686        8/31/2013

   E15687        1/31/2014   

E15690        1/31/2014

E15698        1/31/2014

E15700        2/28/2014

E80434        7/31/2013

E80438        8/31/2013

F36908        2/28/2014

F36909        2/28/2014

F43915        3/31/2014

F43926        3/31/2014

F43927        3/31/2014

 

NORGESTREL 0.3MG/ETHINYL ESTRADIOL 0.03 MG

LOT#         Expiration Date

E15677        8/31/2013

E15704        1/31/2014

E15706        1/31/2014

E80440        8/31/2013

F16388        1/31/2014

F16390        2/28/2014

F22132        2/28/2014

F31330        2/28/2014

F36911        3/31/2014

F36913        3/31/2014

F43924        3/31/2014

F43925        3/31/2014

F43934        3/31/2014

F53238        3/31/2014

January 17, 2012 in Contraception , Cooperative Updates , Health Care , Oral Contraceptives , Pharmaceutical Products , Pharmaceuticals , Sales , Women’s Health | Permalink | TrackBack (0)

February 13, 2008

Kroger Launches Discount Drug Program, Includes Generic Birth Control

Public Release Date: 7-February-2008

On Wednesday, the Cincinnati-based Kroger announced that it will begin selling 30-day supplies of more than 300 generic prescription drugs, including birth control pills, at significant discounts at participating pharmacies nationwide, the Atlanta Journal-Constitution reports.

Continue reading "Kroger Launches Discount Drug Program, Includes Generic Birth Control"

February 13, 2008 in Contraception , Contraceptives , News , Oral Contraceptives , Pharmaceutical Products , Women’s Health | Permalink | TrackBack (0)

May 10, 2007

ACOG: Plan B Availability Varies from State to State

Public Release Date: 9-May-2007

SAN DIEGO -- Those who battled the FDA for non-prescription status of Plan B (levonorgestrel) apparently won only half the struggle. Prescription or not, Plan B can be hard to get.

A survey of Plan B availability in three major cities found that state laws can override the ease of access to the emergency contraception agent, whether by prescription or "under-the-counter" sales.

Continue reading "ACOG: Plan B Availability Varies from State to State"

May 10, 2007 in Contraception , Contraceptives , Health Care , Medical Access , News , Oral Contraceptives , Pharmaceuticals , Public Policy , Women’s Health | Permalink | TrackBack (0)